Cancer Genomic Testing for Oncologists | Anthology Diagnostics NJ   

Comprehensive Cancer Genomic Testing in New Jersey | Anthology Diagnostics

Precision Oncology Services for Personalized Cancer Treatment Decisions

Anthology Diagnostics offers advanced cancer genomic testing based in New Jersey, serving oncology providers throughout the state. A partnership between Hackensack Meridian Health and the Genomic Testing Cooperative, we focus on delivering accurate, clinically relevant molecular data to support oncology teams in making informed, timely treatment decisions.

Located within JFK University Medical Center, we provide next-generation sequencing (NGS) and biomarker testing for solid tumors, hematologic malignancies, and liquid biopsies. Our DNA and RNA-based profiling gives a more complete view of tumor biology, helping to identify actionable targets, stratify risk, and guide therapeutic direction.

Why Choose Our Cancer Genomic Testing Services in New Jersey?

Precision matters in cancer care. We focus on high-utility data that directly supports patient management decisions. Our test offerings include:

  • Solid tumor panels for cancers including lung, colorectal, breast, prostate, and more
  • Hematologic malignancy panels for leukemia, lymphoma, multiple myeloma, and others
  • Liquid biopsy options for non-invasive monitoring when tissue is limited

All major cancer types can be tested with our platform, though sample and tissue requirements vary by test. We provide clear guidelines on specimen collection to ensure test accuracy and timely turnaround.

Our comprehensive approach includes both DNA and RNA analysis to capture mutations, fusions, CNVs, tumor mutational burden, MSI status, and more.

What We Offer to Oncology Providers:

Our reports are designed to highlight FDA-approved therapies, relevant clinical trials, and NCCN-guided treatment options, supporting evidence-based decisions at the point of care.
We offer testing solutions that require smaller sample sizes and deliver faster results than many traditional methods, helping you initiate treatment without unnecessary delays.
We provide reports through a secure provider portal and support integration with electronic health records (EHRs) in both HL7 and PDF formats.
Our genomic tests are covered by Medicare and most major insurers. We also offer direct support to your billing and pathology teams to streamline the reimbursement process.
Our team of molecular pathology experts is available for consultation on test selection, sample handling, and interpretation of complex results to ensure optimal clinical utility.

Provider Resources

We work closely with oncologists, pathologists, and lab directors to ensure our testing meets your clinical and operational needs.

  • Sample reports are available upon request
  • Order instructions and supply kits are provided for ease of use
  • Tissue and blood sample requirements are clearly defined to avoid processing delays
  • Writable PDF forms for test requisitions and new client information are available for streamlined ordering
  • Consultation with our molecular pathology team is available to guide test selection and result interpretation

Ready to get started?

Test Requisition Writable PDF

New Client Writable Information Form

Part of the Genomic Testing Cooperative Network

As a GTC-affiliated laboratory, we are part of a national network focused on advancing genomic insights and data sharing across institutions. This collaboration supports research, clinical trial matching, and the continuous refinement of oncology diagnostics through real-world data and AI modeling.

For a broader look at our role in the oncology ecosystem, explore our work through the Research That Brings Us Together initiative.

Contact Us

Anthology Diagnostics
JFK University Medical Center
80 James St, Edison, NJ 08820
732-321-7240

We use cookies to improve your experience. Please read our Privacy Policy or click Accept.
X